 | • レポートコード：GIR-2104Z00891 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、扁桃炎のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。扁桃炎の種類別市場規模（ベータ遮断薬、カルシウム拮抗薬、抗凝固薬、抗血小板薬、硝酸塩、ACE阻害薬、ラノラジン）、用途別市場規模（診療所、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・扁桃炎の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen、Taxus Cardium Pharmaceuticals、LegoChem Biosciences、Lee’s Pharmaceutical、Milestone Pharmaceuticals、Juventas Therapeutics、ViroMed、Kuhnil Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ベータ遮断薬、カルシウム拮抗薬、抗凝固薬、抗血小板薬、硝酸塩、ACE阻害薬、ラノラジン ・用途別分析2016年-2026年：診療所、病院、その他 ・扁桃炎の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・扁桃炎のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・扁桃炎のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・扁桃炎の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・扁桃炎の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Angina market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Angina size is estimated to be USD 12300 million in 2025 from USD 10550 million in 2019, with a change XX% between 2019 and 2020. The global Angina market size is expected to grow at a CAGR of 3.9% for the next five years.
Market segmentation
Angina market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE inhibitors
Ranolazine
Market segment by Application, can be divided into
Clinics
Hospitals
Other
Market segment by players, this report covers
Amgen
Taxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Angina
1.2 Classification of Angina by Type
1.2.1 Overview: Global Angina Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Angina Revenue Market Share by Type in 2020
1.2.3 Beta Blockers
1.2.4 Calcium Antagonists
1.2.5 Anticoagulants
1.2.6 Antiplatelet
1.2.7 Nitrates
1.2.8 ACE inhibitors
1.2.9 Ranolazine
1.3 Global Angina Market by Application
1.3.1 Overview: Global Angina Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Global Angina Market Size & Forecast
1.5 Global Angina Market Size and Forecast by Region
1.5.1 Global Angina Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Angina Market Size by Region, (2016-2021)
1.5.3 North America Angina Market Size and Prospect (2016-2026)
1.5.4 Europe Angina Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Angina Market Size and Prospect (2016-2026)
1.5.6 South America Angina Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Angina Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Angina Market Drivers
1.6.2 Angina Market Restraints
1.6.3 Angina Trends Analysis
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Angina Product and Solutions
2.1.4 Amgen Angina Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Amgen Recent Developments and Future Plans
2.2 Taxus Cardium Pharmaceuticals
2.2.1 Taxus Cardium Pharmaceuticals Details
2.2.2 Taxus Cardium Pharmaceuticals Major Business
2.2.3 Taxus Cardium Pharmaceuticals Angina Product and Solutions
2.2.4 Taxus Cardium Pharmaceuticals Angina Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Taxus Cardium Pharmaceuticals Recent Developments and Future Plans
2.3 LegoChem Biosciences
2.3.1 LegoChem Biosciences Details
2.3.2 LegoChem Biosciences Major Business
2.3.3 LegoChem Biosciences Angina Product and Solutions
2.3.4 LegoChem Biosciences Angina Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 LegoChem Biosciences Recent Developments and Future Plans
2.4 Lee’s Pharmaceutical
2.4.1 Lee’s Pharmaceutical Details
2.4.2 Lee’s Pharmaceutical Major Business
2.4.3 Lee’s Pharmaceutical Angina Product and Solutions
2.4.4 Lee’s Pharmaceutical Angina Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Lee’s Pharmaceutical Recent Developments and Future Plans
2.5 Milestone Pharmaceuticals
2.5.1 Milestone Pharmaceuticals Details
2.5.2 Milestone Pharmaceuticals Major Business
2.5.3 Milestone Pharmaceuticals Angina Product and Solutions
2.5.4 Milestone Pharmaceuticals Angina Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Milestone Pharmaceuticals Recent Developments and Future Plans
2.6 Juventas Therapeutics
2.6.1 Juventas Therapeutics Details
2.6.2 Juventas Therapeutics Major Business
2.6.3 Juventas Therapeutics Angina Product and Solutions
2.6.4 Juventas Therapeutics Angina Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Juventas Therapeutics Recent Developments and Future Plans
2.7 ViroMed
2.7.1 ViroMed Details
2.7.2 ViroMed Major Business
2.7.3 ViroMed Angina Product and Solutions
2.7.4 ViroMed Angina Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 ViroMed Recent Developments and Future Plans
2.8 Kuhnil Pharmaceutical
2.8.1 Kuhnil Pharmaceutical Details
2.8.2 Kuhnil Pharmaceutical Major Business
2.8.3 Kuhnil Pharmaceutical Angina Product and Solutions
2.8.4 Kuhnil Pharmaceutical Angina Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Kuhnil Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Angina Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Angina Players Market Share
3.2.2 Top 10 Angina Players Market Share
3.2.3 Market Competition Trend
3.3 Angina Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Angina Revenue and Market Share by Type (2016-2021)
4.2 Global Angina Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Angina Revenue Market Share by Application (2016-2021)
5.2 Angina Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Angina Revenue by Type (2016-2026)
6.2 North America Angina Revenue by Application (2016-2026)
6.3 North America Angina Market Size by Country
6.3.1 North America Angina Revenue by Country (2016-2026)
6.3.2 United States Angina Market Size and Forecast (2016-2026)
6.3.3 Canada Angina Market Size and Forecast (2016-2026)
6.3.4 Mexico Angina Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Angina Revenue by Type (2016-2026)
7.2 Europe Angina Revenue by Application (2016-2026)
7.3 Europe Angina Market Size by Country
7.3.1 Europe Angina Revenue by Country (2016-2026)
7.3.2 Germany Angina Market Size and Forecast (2016-2026)
7.3.3 France Angina Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Angina Market Size and Forecast (2016-2026)
7.3.5 Russia Angina Market Size and Forecast (2016-2026)
7.3.6 Italy Angina Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Angina Revenue by Type (2016-2026)
8.2 Asia-Pacific Angina Revenue by Application (2016-2026)
8.3 Asia-Pacific Angina Market Size by Region
8.3.1 Asia-Pacific Angina Revenue by Region (2016-2026)
8.3.2 China Angina Market Size and Forecast (2016-2026)
8.3.3 Japan Angina Market Size and Forecast (2016-2026)
8.3.4 South Korea Angina Market Size and Forecast (2016-2026)
8.3.5 India Angina Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Angina Market Size and Forecast (2016-2026)
8.3.7 Australia Angina Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Angina Revenue by Type (2016-2026)
9.2 South America Angina Revenue by Application (2016-2026)
9.3 South America Angina Market Size by Country
9.3.1 South America Angina Revenue by Country (2016-2026)
9.3.2 Brazil Angina Market Size and Forecast (2016-2026)
9.3.3 Argentina Angina Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Angina Revenue by Type (2016-2026)
10.2 Middle East & Africa Angina Revenue by Application (2016-2026)
10.3 Middle East & Africa Angina Market Size by Country
10.3.1 Middle East & Africa Angina Revenue by Country (2016-2026)
10.3.2 Turkey Angina Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Angina Market Size and Forecast (2016-2026)
10.3.4 UAE Angina Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Angina Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Angina Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Angina Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Angina Revenue (USD Million) by Region (2016-2021)
Table 5. Global Angina Revenue Market Share by Region (2021-2026)
Table 6. Amgen Corporate Information, Head Office, and Major Competitors
Table 7. Amgen Major Business
Table 8. Amgen Angina Product and Solutions
Table 9. Amgen Angina Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Taxus Cardium Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Taxus Cardium Pharmaceuticals Major Business
Table 12. Taxus Cardium Pharmaceuticals Angina Product and Solutions
Table 13. Taxus Cardium Pharmaceuticals Angina Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. LegoChem Biosciences Corporate Information, Head Office, and Major Competitors
Table 15. LegoChem Biosciences Major Business
Table 16. LegoChem Biosciences Angina Product and Solutions
Table 17. LegoChem Biosciences Angina Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Lee’s Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Lee’s Pharmaceutical Major Business
Table 20. Lee’s Pharmaceutical Angina Product and Solutions
Table 21. Lee’s Pharmaceutical Angina Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Milestone Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Milestone Pharmaceuticals Major Business
Table 24. Milestone Pharmaceuticals Angina Product and Solutions
Table 25. Milestone Pharmaceuticals Angina Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Juventas Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Juventas Therapeutics Major Business
Table 28. Juventas Therapeutics Angina Product and Solutions
Table 29. Juventas Therapeutics Angina Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. ViroMed Corporate Information, Head Office, and Major Competitors
Table 31. ViroMed Major Business
Table 32. ViroMed Angina Product and Solutions
Table 33. ViroMed Angina Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Kuhnil Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 35. Kuhnil Pharmaceutical Major Business
Table 36. Kuhnil Pharmaceutical Angina Product and Solutions
Table 37. Kuhnil Pharmaceutical Angina Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Angina Revenue (USD Million) by Players (2019-2021)
Table 39. Global Angina Revenue Share by Players (2019-2021)
Table 40. Breakdown of Angina by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Angina Players Head Office, Products and Services Provided
Table 42. Angina Mergers & Acquisitions in the Past Five Years
Table 43. Angina New Entrants and Expansion Plans
Table 44. Global Angina Revenue (USD Million) by Type (2016-2021)
Table 45. Global Angina Revenue Share by Type (2016-2021)
Table 46. Global Angina Revenue Forecast by Type (2021-2026)
Table 47. Global Angina Revenue by Application (2016-2021)
Table 48. Global Angina Revenue Forecast by Application (2021-2026)
Table 49. North America Angina Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Angina Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Angina Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Angina Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Angina Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Angina Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Angina Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Angina Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Angina Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Angina Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Angina Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Angina Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Angina Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Angina Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Angina Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Angina Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Angina Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Angina Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Angina Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Angina Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Angina Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Angina Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Angina Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Angina Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Angina Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Angina Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Angina Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Angina Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Angina Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Angina Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Angina Picture
Figure 2. Global Angina Revenue Market Share by Type in 2020
Figure 3. Beta Blockers
Figure 4. Calcium Antagonists
Figure 5. Anticoagulants
Figure 6. Antiplatelet
Figure 7. Nitrates
Figure 8. ACE inhibitors
Figure 9. Ranolazine
Figure 10. Angina Revenue Market Share by Application in 2020
Figure 11. Clinics Picture
Figure 12. Hospitals Picture
Figure 13. Other Picture
Figure 14. Global Angina Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Angina Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Angina Revenue Market Share by Region (2016-2026)
Figure 17. Global Angina Revenue Market Share by Region in 2020
Figure 18. North America Angina Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Angina Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Angina Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Angina Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Angina Market Drivers
Figure 23. Angina Market Restraints
Figure 24. Angina Market Trends
Figure 25. Amgen Recent Developments and Future Plans
Figure 26. Taxus Cardium Pharmaceuticals Recent Developments and Future Plans
Figure 27. LegoChem Biosciences Recent Developments and Future Plans
Figure 28. Lee’s Pharmaceutical Recent Developments and Future Plans
Figure 29. Milestone Pharmaceuticals Recent Developments and Future Plans
Figure 30. Juventas Therapeutics Recent Developments and Future Plans
Figure 31. ViroMed Recent Developments and Future Plans
Figure 32. Kuhnil Pharmaceutical Recent Developments and Future Plans
Figure 34. Global Angina Revenue Share by Players in 2020
Figure 35. Angina Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Angina Revenue Market Share in 2020
Figure 37. Global Top 10 Players Angina Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Angina Revenue Share by Type in 2020
Figure 40. Global Angina Market Share Forecast by Type (2021-2026)
Figure 41. Global Angina Revenue Share by Application in 2020
Figure 42. Global Angina Market Share Forecast by Application (2021-2026)
Figure 43. North America Angina Sales Market Share by Type (2016-2026)
Figure 44. North America Angina Sales Market Share by Application (2016-2026)
Figure 45. North America Angina Revenue Market Share by Country (2016-2026)
Figure 46. United States Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Angina Sales Market Share by Type (2016-2026)
Figure 50. Europe Angina Sales Market Share by Application (2016-2026)
Figure 51. Europe Angina Revenue Market Share by Country (2016-2026)
Figure 52. Germany Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Angina Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Angina Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Angina Revenue Market Share by Region (2016-2026)
Figure 60. China Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Angina Sales Market Share by Type (2016-2026)
Figure 67. South America Angina Sales Market Share by Application (2016-2026)
Figure 68. South America Angina Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Angina Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Angina Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Angina Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Angina Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の狭心症市場規模・現状・予測（2021年-2027年） Angina is a type of chest pain caused by reduced blood flow to the heart. Angina (an-JIE-nuh or AN-juh-nuh) is a symptom of coronary artery disease. Angina, which may also be called angina pectoris, is often described as squeezing, pressure, heaviness, tightness or pain in your chest Market Analysis…- 世界の狭心症治療薬市場規模・現状・予測（2021年-2027年） Angina pectoris is a clinical indication characterized by precordial heaviness or discomfort due to transient myocardial ischemia without infarction, elicited by physical exertion or psychological stress. Angina pectoris is categorized as - stable, unstable, microvascular and Prinzmetal / variant. A…
- 世界の狭心症用ニトログリセリン市場 2021：企業別、地域別、種類・用途別 The Nitroglycerin for Angina market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の心臓リハビリテーション市場規模・現状・予測（2021年-2027年） Cardiac Rehabilitation is the process by which patients with cardiac disease, in partnership with a multidisciplinary team of health professionals are encouraged to support and achieve and maintain optimal physical and psychosocial health. The involvement of partners, other family members are also i…
- 世界のジルチアゼム市場 2021：企業別、地域別、種類・用途別 The Diltiazem market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent d…